Why This Key Analyst Believes That Apple’s New iPhone Won’t Live Up to the Hype

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why This Key Analyst Believes That Apple’s New iPhone Won’t Live Up to the Hype

© courtesy of Apple Inc.

Is Apple Inc. (NASDAQ: AAPL) poised to hit record numbers with its upcoming iPhone release, or will the smartphone giant have an average showing? Most analysts are fairly bullish on their expectations for shipments of the upgraded iPhone 7S, iPhone 7S Plus and iPhone 8. However, Deutsche Bank is taking a less-than bullish stance on Apple and what it can deliver for this next iPhone cycle.

Deutsche Bank currently estimates that Apple will ship about 230 million units in fiscal 2018, which falls short of the Wall Street consensus of 244 million units.

Analysts at Credit Suisse and Instinet believe that Apple is poised for a “supercycle,” similar to what we saw when the firm released the iPhone 6 and iPhone 6 Plus back in fiscal 2015, shipping 231 million units. But Deutsche Bank isn’t buying it and sees only a regular upgrade cycle happening with this upcoming release.

[nativounit]

In a sense, Deutsche Bank believes that Wall Street expectations are a little lofty and that investors may be disappointed in the coming fiscal years, despite the amazing features and functions that the new iPhone will offer.

Deutsche Bank had this to say:

The market has become overly optimistic on iPhone’s potential sales into the upcoming iPhone launch this fall, and is ignoring the fundamental challenges Apple faces in the smartphone market, which include saturation in mature markets, elongating refresh cycles, declining share plus increased competition in China, and a growing secondary market.

Keep in mind that this new smartphone could be the most expensive iPhone to hit the market, with pricing at or around $1,200.

Shares of Apple were recently trading at $144.65, with a consensus analyst price target of $158.95 and a 52-week range of $96.42 to $156.65.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618